Adding ezetimibe to statin therapy: latest evidence and clinical implications

Adding ezetimibe to statin therapy: latest evidence and clinical implications

Background: Statins are the hypolipemic treatment of choice for hyperlipidemia with confirmed atherosclerotic cardiovascular disease (ASCVD) protective effect, proven even in normolipemic patients. But in rare situations, even with a high-dose treatment regimen, or maximally tolerated statin dose tr...

Full description

Bibliographic Details
Main Authors: Marija Vavlukis, Ana Vavlukis
Format: Article
Language:English
Published: BioExcel Publishing Ltd 2018-07-01
Series:Drugs in Context
Subjects:
adverse effects
cardiovascular diseases
cerebrovascular disease
diabetes
ezetimibe
hydroxymethylglutaryl-CoA reductase inhibitors
hyperlipidemias
low-density lipoprotein cholesterol
prevention
residual risk
Online Access:https://www.drugsincontext.com/adding-ezetimibe-to-statin-therapy-latest-evidence-and-clinical-implications

Internet

https://www.drugsincontext.com/adding-ezetimibe-to-statin-therapy-latest-evidence-and-clinical-implications

Similar Items